Upstream Bio Inc
UPB15.705USD
+0.165+1.06%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
842.43MMarket Cap
LossP/E TTM
Upstream Bio Inc
15.705
+0.165+1.06%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q1
FY2023Q4
FY2023Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-134.40%-41.16M
-21.74%-19.61M
-189.73%-13.96M
---17.56M
---16.11M
---4.82M
Net income from continuing operations
-150.32%-27.27M
-79.51%-21.24M
-415.54%-15.99M
---10.89M
---11.83M
---3.10M
Operating gains losses
230.77%43.00K
250.00%49.00K
-17.65%14.00K
--13.00K
--14.00K
--17.00K
Other non-cash items
53.74%-1.60M
167.19%813.00K
89.70%-564.00K
---3.46M
---1.21M
---5.47M
Change in working capital
-287.57%-14.97M
66.15%-1.32M
-76.55%717.00K
---3.86M
---3.89M
--3.06M
-Change in receivables
107.34%47.00K
-103.59%-6.00K
44.89%-97.00K
---640.00K
--167.00K
---176.00K
-Change in prepaid expenses
-707.58%-13.74M
64.92%-2.09M
-75.86%710.00K
---1.70M
---5.96M
--2.94M
-Change in other current liabilities
----
----
----
----
---482.00K
---446.00K
Cash from non-recurring investing activities
Cash from operating activities
-134.40%-41.16M
-21.74%-19.61M
-189.73%-13.96M
---17.56M
---16.11M
---4.82M
Investing cash flow
Net cash from continuing investing activities
----
--185.00K
--326.00K
----
--0.00
--0.00
Capital expenditures
----
--185.00K
--326.00K
----
--0.00
--0.00
Net cash flow from disposal of fixed assets
----
--185.00K
--326.00K
----
--0.00
--0.00
Net cash flow from investment products
-1640.43%-213.38M
903.00%42.09M
-85.84%1.73M
--13.85M
---5.24M
--12.25M
Cash from non-current investing activities
Net cash flow from investing activities
-1640.43%-213.38M
899.47%41.91M
-88.50%1.41M
--13.85M
---5.24M
--12.25M
Financing cash flow
Cash flow from continuous financing activities
-100.36%-34.00K
203594.74%270.65M
-3382.00%-1.64M
--9.39M
---133.00K
--50.00K
Net cash flow from common stock issuance/repurchase
----
--272.72M
----
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
-100.00%0.00
----
----
--49.43M
--49.56M
Proceeds from stock option exercised by employees
----
--28.00K
-81.00%19.00K
--12.00K
--0.00
--100.00K
Net cash flow from other financing activities
-100.36%-34.00K
95.76%-2.10M
96.65%-1.66M
--9.38M
---49.56M
---49.62M
Net cash from non-recurrent financing activities
Net cash from financing activities
-100.36%-34.00K
203594.74%270.65M
-3382.00%-1.64M
--9.39M
---133.00K
--50.00K
Net cash flow
Beginning cash balance
1162.28%326.09M
-29.96%33.14M
18.82%47.34M
--25.83M
--47.32M
--39.84M
Current period cash flow changes
-4584.41%-254.58M
1463.48%292.94M
-289.76%-14.19M
--5.68M
---21.48M
--7.48M
Ending cash balance
126.93%71.51M
1162.28%326.09M
-29.96%33.14M
--31.51M
--25.83M
--47.32M
Free cash flow
-134.40%-41.16M
-22.89%-19.80M
-196.49%-14.29M
---17.56M
---16.11M
---4.82M
Currency unit
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
